Navigation Links
Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
Date:2/28/2011

T-cell levels and no detectable viral load on long-term HAART.  The trial has three dosing cohorts.  Subjects will remain on their existing antiviral therapy while receiving treatment with SB-728-T. A fourth cohort, of up to four subjects who have failed HAART and have measureable viral loads, was recently added to the study.  No data from subjects in the last two cohorts of this study were reported in today's CROI presentation. The primary objective of the study is to evaluate the safety and tolerability of SB-728-T. In addition to safety monitoring, data are being collected on the expansion, trafficking and persistence of SB-728-T, total CD4+ T-cell counts, CD4:CD8 T-cell ratios and viral load.

Dr. June has no financial relationship with Sangamo BioSciences, Inc.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification.  The most advanced ZFP Therapeutic® development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has a Phase 1 / 2 clinical trial and two ongoing Phase 1 clinical trials to evaluate the safety and efficacy for the treatment of HIV/AIDS as well as a Phase 1 trial for the treatment for recurrent glioblastoma multiforme. Other therapeutic programs are focused on Parkinson's disease, monogenic diseases, neuropathic pain and nerve regeneration.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developing sequence-specific ZFP Nucleases (ZFNs) for gene modification.  Sangamo has
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources ... market will grow strongly through 2022 at a ... This will be largely supported by strong population ... increase demand for imaging procedures. The Indian government,s ... more facilities to purchase or upgrade diagnostic imaging ...
(Date:8/28/2014)... OSAKA, Japan , Aug. 28, 2014 /PRNewswire/ ... completion of the post-marketing commitment and submissions of ... authorities including the United States ... European Medicines Agency (EMA) and the Japanese Ministry ... Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for ...
(Date:8/28/2014)... SALT LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ ... in 2000 by service academy graduates, has published a ... its concentrated, three-day Leadership Excellence Course . In ... the  Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
Breaking Medicine Technology:Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... Feb. 17, 2011 Greenway Medical Technologies, Inc., an ... with HP to offer medical practices custom electronic health ... and improve quality of care. Greenway,s ... solution and HP hardware will be available to provide ...
... ATLANTA, Feb. 17, 2011 Ingenious Med, the leading ... its solution is now available on the App Store ... being launched as part of the company,s presence at ... The application enables Ingenious Med,s 9,000 users to access ...
Cached Medicine Technology:Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 2Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 3Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 4HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2
(Date:8/29/2014)... 29, 2014 As a chiropractic physician ... understands that there’s a direct connection between the condition ... and back. "Since conventional shoe inserts and orthotics weren’t ... of my own," he said. , Customizable to a ... support for the foot in order to help prevent ...
(Date:8/29/2014)... (HealthDay News) -- Researchers have discovered that people with ... Dyslexia -- the most commonly diagnosed learning disorder in ... writing. Previous research showed that brain activity is ... studies focused only on a small number of brain ... analyze how multiple brain regions use networks to communicate ...
(Date:8/29/2014)... August 29, 2014 Empty Nest ... at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers and fathers, ... money, marital bliss, prodding, laughing and sweating through ... house this week. Relief and parenting pride ... what.” Dr. Carol Francis as a ...
(Date:8/29/2014)... "I have had many hospital stays, including ... many other surgeries in my lifetime, as I am a ... stays, I was unable to move freely in order to ... freely had to physically rotate me every 30 minutes to ... and pulled the sheets. This was jarring and caused me ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Scientists from ... idea that progression-free survival correlates with overall survival of ... the new research. Click here to read it ... The Netherlands studied the cases of 523 mesothelioma ... studies. , “PFSR-18 [progression-free survival at 18 weeks ...
Breaking Medicine News(10 mins):Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2
... (HealthDay News) -- New genetic mapping of children with ... gene mutation are particularly well-skilled in the use of ... specific variation of the so-called "PCSK6 gene" and hand-motor ... to suggest that there could be an association between ...
... Japanese research group led by Prof. Ryusuke Kakigi and ... and Prof. Masami K Yamaguchi (Chuo University) found that ... temporal sulcus (STS) when processing positive (happy) and negative ... reported in NeuroImage . Near infrared spectroscopy ...
... , THURSDAY, Nov. 4 (HealthDay News) -- During ... clothes to keep infants warm can lead to dangerous ... syndrome (SIDS), U.S. experts warn. Infants are sensitive ... their body temperature. Research has shown that multiple layers ...
... children, especially those with eczema, are unnecessarily avoiding ... according to researchers at National Jewish Health. The ... children, and is often based primarily on data ... factors, including patient and family history, physical examination, ...
... Cambridge hope to revolutionise cancer therapy after discovering one of ... system to treat cancerous tumours have failed. New ... that a type of stromal cell found in many cancers ... role in suppressing the immune response in cancerous tumours ...
... could help smuggle drugs into the gut, according to ... Journal of Nanotechnology . There are several drugs ... could be targeted at absorption by the lower intestine. ... colon cancer for instance, medication delivered by mouth must ...
Cached Medicine News:Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:Infants' hemodynamic responses to happy and angry facial expressions 2Health News:Overheating in Infants Can Lead to SIDS, Experts Warn 2Health News:Food-allergy fears drive overly restrictive diets 2Health News:Food-allergy fears drive overly restrictive diets 3Health News:Breakthrough in cancer vaccine research 2Health News:Colonic navigation 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: